Hawkins [HWKN] vs Eastman Chemical [EMN] Detailed Stock Comparison
Hawkins
NASDAQ
Loading...
Eastman Chemical
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Hawkins wins in 8 metrics, Eastman Chemical wins in 12 metrics, with 0 ties. Eastman Chemical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Hawkins | Eastman Chemical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 42.35 | 9.29 | Eastman Chemical |
| Price-to-Book Ratio | 7.33 | 1.30 | Eastman Chemical |
| Debt-to-Equity Ratio | 63.70 | 90.60 | Hawkins |
| PEG Ratio | 29.43 | -0.25 | Eastman Chemical |
| EV/EBITDA | 23.68 | 6.79 | Eastman Chemical |
| Profit Margin (TTM) | 8.37% | 8.96% | Eastman Chemical |
| Operating Margin (TTM) | 14.09% | 12.42% | Hawkins |
| EBITDA Margin (TTM) | 14.09% | 12.42% | Hawkins |
| Return on Equity | 18.69% | 14.39% | Hawkins |
| Return on Assets (TTM) | 8.92% | 5.54% | Hawkins |
| Free Cash Flow (TTM) | $70.00M | $688.00M | Eastman Chemical |
| Dividend Yield | 0.57% | 3.31% | Eastman Chemical |
| 1-Year Return | 35.83% | -31.11% | Hawkins |
| Price-to-Sales Ratio (TTM) | 3.54 | 0.82 | Eastman Chemical |
| Enterprise Value | $3.87B | $12.52B | Eastman Chemical |
| EV/Revenue Ratio | 3.83 | 1.35 | Eastman Chemical |
| Gross Profit Margin (TTM) | 24.67% | 22.13% | Hawkins |
| Revenue per Share (TTM) | $49 | $80 | Eastman Chemical |
| Earnings per Share (Diluted) | $4.05 | $7.11 | Eastman Chemical |
| Beta (Stock Volatility) | 0.81 | 1.23 | Hawkins |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Hawkins vs Eastman Chemical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Hawkins | 1.15% | -0.86% | 5.51% | 34.23% | 61.33% | 41.02% |
| Eastman Chemical | 5.20% | 5.92% | -12.18% | -14.65% | -29.31% | -21.55% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Hawkins | 35.83% | 309.41% | 562.63% | 810.71% | 978.19% | 2,515.85% |
| Eastman Chemical | -31.11% | -26.94% | -6.70% | -4.50% | 127.23% | 186.71% |
Performance & Financial Health Analysis: Hawkins vs Eastman Chemical
| Metric | HWKN | EMN |
|---|---|---|
| Market Information | ||
| Market Cap | $3.58B | $7.58B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 211,420 | 1,553,501 |
| 90 Day Avg. Volume | 219,587 | 1,729,367 |
| Last Close | $170.03 | $69.44 |
| 52 Week Range | $98.30 - $185.50 | $56.78 - $114.50 |
| % from 52W High | -8.34% | -39.35% |
| All-Time High | $185.16 (Aug 12, 2025) | $130.47 (May 31, 2021) |
| % from All-Time High | -8.17% | -46.78% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | -0.03% |
| Quarterly Earnings Growth | 0.01% | -0.39% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.09% |
| Operating Margin (TTM) | 0.14% | 0.12% |
| Return on Equity (TTM) | 0.19% | 0.14% |
| Debt to Equity (MRQ) | 63.70 | 90.60 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $23.39 | $50.84 |
| Cash per Share (MRQ) | $0.70 | $3.69 |
| Operating Cash Flow (TTM) | $125.00M | $1.00B |
| Levered Free Cash Flow (TTM) | $63.02M | $381.75M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.57% | 3.31% |
| Last 12-Month Dividend | $0.91 | $2.47 |
Valuation & Enterprise Metrics Analysis: Hawkins vs Eastman Chemical
| Metric | HWKN | EMN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 42.35 | 9.29 |
| Forward P/E | 40.16 | 7.59 |
| PEG Ratio | 29.43 | -0.25 |
| Price to Sales (TTM) | 3.54 | 0.82 |
| Price to Book (MRQ) | 7.33 | 1.30 |
| Market Capitalization | ||
| Market Capitalization | $3.58B | $7.58B |
| Enterprise Value | $3.87B | $12.52B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.83 | 1.35 |
| Enterprise to EBITDA | 23.68 | 6.79 |
| Risk & Other Metrics | ||
| Beta | 0.81 | 1.23 |
| Book Value per Share (MRQ) | $23.39 | $50.84 |
Financial Statements Comparison: Hawkins vs Eastman Chemical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HWKN | EMN |
|---|---|---|
| Revenue/Sales | $245.32M | $2.29B |
| Cost of Goods Sold | $193.08M | $1.72B |
| Gross Profit | $52.24M | $567.00M |
| Research & Development | N/A | $67.00M |
| Operating Income (EBIT) | $24.58M | $318.00M |
| EBITDA | $34.53M | $442.00M |
| Pre-Tax Income | $22.42M | $253.00M |
| Income Tax | $6.10M | $70.00M |
| Net Income (Profit) | $16.33M | $183.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HWKN | EMN |
|---|---|---|
| Cash & Equivalents | $5.10M | $418.00M |
| Total Current Assets | $230.69M | $3.90B |
| Total Current Liabilities | $107.14M | $2.27B |
| Long-Term Debt | $149.83M | $4.74B |
| Total Shareholders Equity | $460.29M | $5.94B |
| Retained Earnings | $434.26M | $10.10B |
| Property, Plant & Equipment | $13.45M | $14.13B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HWKN | EMN |
|---|---|---|
| Operating Cash Flow | $27.00M | $-167.00M |
| Capital Expenditures | $-11.09M | $-147.00M |
| Free Cash Flow | $19.76M | $-314.00M |
| Debt Repayment | $-10.00M | $-550.00M |
| Common Stock Repurchase | $-14.07M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HWKN | EMN |
|---|---|---|
| Shares Short | 1.02M | 2.66M |
| Short Ratio | 4.60 | 1.67 |
| Short % of Float | 0.06% | 0.03% |
| Average Daily Volume (10 Day) | 211,420 | 1,553,501 |
| Average Daily Volume (90 Day) | 219,587 | 1,729,367 |
| Shares Outstanding | 20.68M | 115.17M |
| Float Shares | 19.12M | 113.76M |
| % Held by Insiders | 0.08% | 0.01% |
| % Held by Institutions | 0.73% | 0.91% |
Dividend Analysis & Yield Comparison: Hawkins vs Eastman Chemical
| Metric | HWKN | EMN |
|---|---|---|
| Last 12-Month Dividend | $0.91 | $2.47 |
| Last 12-Month Dividend Yield | 0.57% | 3.31% |
| 3-Year Avg Annual Dividend | $0.71 | $2.94 |
| 3-Year Avg Dividend Yield | 0.23% | 0.92% |
| 3-Year Total Dividends | $2.13 | $8.82 |
| Ex-Dividend Date | Aug 15, 2025 | Mar 14, 2025 |